Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mak, D.-O. D.
Right arrow Articles by Foskett, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mak, D.-O. D.
Right arrow Articles by Foskett, J. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 32, 22231-22237, August 6, 1999


ATP Regulation of Type 1 Inositol 1,4,5-Trisphosphate Receptor Channel Gating by Allosteric Tuning of Ca2+ Activation*

Don-On Daniel MakDagger , Sean McBrideDagger , and J. Kevin FoskettDagger §

From the Dagger  Department of Physiology and § Institute for Human Gene Therapy, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6100

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Inositol 1,4,5-trisphosphate (InsP3) mobilizes intracellular Ca2+ by binding to its receptor (InsP3R), an endoplasmic reticulum-localized Ca2+ release channel. Patch clamp electrophysiology of Xenopus oocyte nuclei was used to study the effects of cytoplasmic ATP concentration on the cytoplasmic Ca2+ ([Ca2+]i) dependence of single type 1 InsP3R channels in native endoplasmic reticulum membrane. Cytoplasmic ATP free-acid ([ATP]i), but not the MgATP complex, activated gating of the InsP3-liganded InsP3R, by stabilizing open channel state(s) and destabilizing the closed state(s). Activation was associated with a reduction of the half-maximal activating [Ca2+]i from 500 ± 50 nM in 0 [ATP]i to 29 ± 4 nM in 9.5 mM [ATP]i, with apparent ATP affinity = 0.27 ± 0.04 mM, similar to in vivo concentrations. In contrast, ATP was without effect on maximum open probability or the Hill coefficient for Ca2+ activation. Thus, ATP enhances gating of the InsP3R by allosteric regulation of the Ca2+ sensitivity of the Ca2+ activation sites of the channel. By regulating the Ca2+-induced Ca2+ release properties of the InsP3R, ATP may play an important role in shaping cytoplasmic Ca2+ signals, possibly linking cell metabolic state to important Ca2+-dependent processes.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Modulation of free cytoplasmic Ca2+ concentration ([Ca2+]i) is a ubiquitous cellular signaling system. In many cell types, binding of ligands to plasma membrane receptors activates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by membrane-bound phospholipase C, generating inositol 1,4,5-trisphosphate (InsP3).1 InsP3 causes the release of Ca2+ from the endoplasmic reticulum (ER) by binding to its receptor (InsP3R), which itself is a Ca2+ channel (1-3). Complex control of Ca2+ release through the InsP3R by various intracellular factors, including cooperative activation by InsP3 (4-8) and biphasic feedback from the permeant Ca2+ ion (6, 8-11) generates intricate [Ca2+]i signals that can be manifested temporally as repetitive spikes or oscillations, with frequencies often tuned to the level of stimulation, and spatially as propagating waves or highly localized events (2, 12, 14) and display properties of "adaptation" and "quantal release," which are poorly understood (15). Several types of InsP3R as products of different genes with alternatively spliced isoforms have been identified and sequenced (16, 17). The InsP3Rs have about 2700 amino acid residues in InsP3 binding, regulatory (modulatory) and transmembrane channel domains (16-18). The sequences of the regulatory domains of all InsP3R isoforms include putative ATP-binding site(s) (17). ATP was shown to bind to the InsP3R (19) and regulate InsP3R-mediated Ca2+ release (20-24), although the detailed mechanisms of this regulation remain unclear.

Several studies have demonstrated that mitochondria and the ER are in close physical and functional proximity in many cell types, including neurons (24-27). [Ca2+]i signals generated by InsP3R-mediated Ca2+ release from the ER appear to be rapidly and efficiently transmitted to mitochondria (28-30), acutely affecting mitochondrial functions (31-33), including ATP synthesis (34). It is unknown, however, whether the communication between these two organelles is reciprocal. ATP release from mitochondria, globally into the cytoplasm and locally into the vicinity of the InsP3R channels that are in close apposition, may provide a signaling pathway for communication from the mitochondria back to the ER. Thus, regulation of the InsP3R by ATP could have considerable significance for intracellular signaling, particularly if the channel is sensitive to ATP levels in normal physiological as well as pathological conditions, including ischemia.

Most previous studies of ATP regulation of the InsP3R have been limited to indirect measurements, i.e. Ca2+ fluxes or concentrations, to infer InsP3R channel activity, because the intracellular location of the Ca2+ release channel has limited its accessibility to electrophysiological approaches. Furthermore, only a limited range of [Ca2+]i was examined in previous studies, despite the fact that the InsP3R is intricately regulated by [Ca2+]i (6, 8-11) and that the primary known regulator of the channel, InsP3, mediates its effects by modulating the [Ca2+]i dependence of channel gating (8). Therefore, in the present study, we have systematically investigated the effects of cytoplasmic ATP concentration on the [Ca2+]i response of single InsP3R channels. We applied the patch clamp technique to isolated Xenopus oocyte nuclei (35-37) to study the single channel activities of the type 1 InsP3R (InsP3R-1), the major brain isoform (38, 39), in its native ER membrane environment under rigorously defined conditions on both the cytoplasmic and luminal sides of the channel. Our results demonstrate that cytoplasmic ATP free acid, but not cytoplasmic MgATP complex, activates the gating of the InsP3R primarily by allosteric regulation of the [Ca2+]i sensitivity of the Ca2+ activation sites of the channel. By regulating the Ca2+-induced Ca2+ release properties of the InsP3R, ATP may play an important role in shaping the extent and duration of [Ca2+]i signals, possibly linking cell metabolic state to important Ca2+-dependent process including synaptic plasticity.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Patch Clamping the Oocyte Nucleus-- Patch clamp experiments were performed as described in Refs. 8, 35, 36, and 40. Briefly, stage V or VI oocytes were opened mechanically just prior to use. The nucleus was separated from the cytoplasm and transferred to a dish on the stage of a microscope for patch-clamping. The oocyte expresses only a single InsP3R isoform (type 1) and lacks other (e.g. ryanodine receptor) Ca2+ release channels (41). Experiments were done in "on-nucleus" configuration, with the solution in the perinuclear lumen between the outer and inner nuclear membranes in apparent equilibrium with the bath solution (35) and with the cytoplasmic aspect of the InsP3R channel facing into the patch pipette. Following standard conventions, the applied potential is that of the pipette electrode minus the reference bath electrode (positive current flows from pipette outward). Experiments were performed at room temperature with the pipette electrode at +20 mV relative to the reference bath electrode.

Data Acquisition and Analysis-- Single channel currents were amplified with an Axopatch-1D amplifier (Axon Instruments, Foster City, CA) with antialiasing filtering at 1 kHz, transferred to a Power Macintosh 8100 via an ITC-16 interface (Instrutech Corp., Great Lake, NY), digitized at 5 kHz, and written directly onto the hard disc by Pulse+PulseFit software (HEKA Elektronik, Lambrecht, Germany). Data were analyzed to identify channel opening and closing events and evaluate channel open probabilities using MacTac 3 (Bruxton, Seattle, WA). Each data point shown is the mean of results from at least four separate patch clamp experiments performed under the same conditions. Error bars indicate the S.E. Theoretical curves were fitted to experimental data using Igor Pro 3 (WaveMetrics, Lake Oswego, OR).

Solutions for Patch Clamp Experiments-- All patch clamp experiments were performed with solutions containing 140 mM KCl and 10 mM HEPES with pH adjusted to 7.1 using KOH. Since the luminal [Ca2+] or [ATP] have no systematic effects on the open probability response of the InsP3R (8), a bath solution containing no ATP and 250 nM free Ca2+ was used in all experiments. Pipette solutions contained various concentrations of nucleotides (sodium salts of ATP, ADP, AMP, GTP, and UTP and adenosine, from Sigma) as specified. Because of chelation of Mg2+ by ATP, the actual free [Mg2+] and free [ATP] in the solutions containing Mg2+ and ATP were calculated by the Maxchelator software (C. Patton, Stanford University, Stanford, CA). By using K+ as the current carrier and appropriate quantities of the high affinity Ca2+ chelator, BAPTA (100-500 µM; Molecular Probes, Inc., Eugene, OR), the low affinity Ca2+ chelator, 5,5'-dibromo-BAPTA (100-350 µM; Molecular Probes), or just ATP (0 or 0.5 mM) to buffer [Ca2+] in the experimental solutions, [Ca2+] was tightly controlled in our experiments. Total Ca2+ content (60-370 µM) in the solutions was determined by induction-coupled plasma mass spectrometry (Mayo Medical Laboratory, Rochester, MN). Free [Ca2+] was calculated using the Maxchelator software. Pipette solutions contained 10 µM InsP3 (Molecular Probes).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Activation of Channel Gating by ATP-- To examine the effects of ATP on the permeation and gating properties of the InsP3R, we included 10 µM InsP3, 250 nM free Ca2+, and 0.5 mM free ATP in the pipette solution. Under these conditions, the endogenous Xenopus type 1 InsP3R channel exhibited channel conductance properties and kinetics similar to those observed previously under similar conditions (8, 40). The channels gated with a moderately high open probability (Po) of ~0.5 (Fig. 1A). In similar experiments employing pipette solutions that lacked ATP, the InsP3R channel Po was significantly lower (~0.2) in either the absence or presence of 3 mM Mg2+ (Fig. 1, B and C). To determine whether the ATP activation of the channel Po was mediated by MgATP, which could suggest a role for ATP hydrolyisis or phosphorylation, similar experiments were undertaken with 3 mM total Mg2+ and 0.5 mM total ATP in the pipette. Under these conditions, [MgATP] is approximately 0.5 mM, and the free Mg2+ concentration ([Mg2+]i) and the cytoplasmic free ATP concentration ([ATP]i) were calculated to be 2.5 and 0.012 mM, respectively. Nevertheless, Po remained low (Fig. 1D). The low Po in the presence of MgATP (Fig. 1) was solely caused by ATP complexation by Mg2+, since it was fully reversed by adding more ATP to the pipette solution to restore [ATP]i (Fig. 1E). Thus, MgATP has no effect, stimulatory or inhibitory, on InsP3R activity. We previously demonstrated that the Po of the Xenopus type 1 InsP3R is independent of [Mg2+]i up to 9.5 mM (40). Taken together, these results suggest that ATP free acid (ATP3- or ATP4-) was the relevant ionic species and that ATP hydrolysis was not involved in the stimulation of InsP3R channel gating.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 1.   Typical current traces of InsP3R channels in outer nuclear membrane at [Ca2+]i = 250 ± 20 nM under various [ATP]i and [Mg2+]i. The arrows indicate closed channel current levels. A, [ATP]i = 0.5 mM; [Mg2+]i = 0 mM. B, [ATP]i = 0 mM; [Mg2+]i = 0 mM. C, [ATP]i = 0 mM; [Mg2+]i = 3.0 mM. D, [ATP]i = 12 µM; [Mg2+]i = 2.5 mM (0.5 mM total ATP; 3 mM total Mg2+). Reduction of InsP3R channel conductance in the presence of Mg2+ (C and D) is caused by permeant ion block of the channel by the divalent cation (40). E, [ATP]i = 1.9 mM; [Mg2+]i = 113 µM (4.8 mM total ATP; 3 mM total Mg2+).

Effects of ATP on the [Ca2+]i Dependence of InsP3R Gating-- InsP3 activates the InsP3R by modulating the sensitivity of the channel to [Ca2+]i (8). To determine the mechanism of ATP activation of the InsP3R channel gating, we investigated in detail the effects of ATP on the channel kinetics of the InsP3R over a wide range of [Ca2+]i. A systematic series of patch clamp experiments were performed using pipette solutions containing various [Ca2+]i with 0.5 mM ATP alone, 3 mM Mg2+ alone, 0.5 mM ATP, and 3 mM Mg2+ (calculated [ATP]i = 0.012 mM; calculated [Mg2+]i = 2.5 mM) or no ATP or Mg2+. To avoid possible effects of Ca2+ on InsP3 binding, a functionally saturating InsP3 concentration of 10 µM was used (8). The [Ca2+]i sensitivity of the InsP3R in the absence of cytoplasmic free ATP was biphasic (Fig. 2) and could be well fitted with a biphasic Hill equation similar to the following one previously derived for the InsP3R in the presence of 0.5 mM cytoplasmic free ATP (8).
P<SUB><UP>o</UP></SUB>=P<SUB><UP>max</UP></SUB>{1+(K<SUB><UP>act</UP></SUB>/[<UP>Ca<SUP>2+</SUP></UP>]<SUB>i</SUB>)<SUP>H<SUB><UP>act</UP></SUB></SUP>}<SUP><UP>−1</UP></SUP>{1+([<UP>Ca<SUP>2+</SUP></UP>]<SUB>i</SUB>/K<SUB><UP>inh</UP></SUB>)<SUP>H<SUB><UP>inh</UP></SUB></SUP>}<SUP><UP>−1</UP></SUP>. (Eq. 1)
Similar results were obtained independent of the presence or absence of either Mg2+ or MgATP in the pipette solutions. This result indicates that the InsP3R can achieve a maximum open probability Pmax of 0.79 in the absence of cytoplasmic free ATP, a level of activity very similar to the Pmax of 0.81 found in the presence of 0.5 mM cytoplasmic free ATP (8). Thus, ATP does not activate the channel by increasing Pmax. The Hill coefficient for Ca2+ activation Hact was 2.4 ± 0.6 in the absence of free ATP, similar to Hact = 1.9 ± 0.3 in the presence of 0.5 mM free ATP. This result suggests that Ca2+ probably activates the InsP3R via the same cooperative process in either the presence or absence of cytoplasmic free ATP. Thus, ATP does not activate the channel by modulating Hact. The observed activation of the InsP3R by cytoplasmic free ATP (Fig. 1) was associated with a reduction of the half-maximal activating [Ca2+]i (Kact) from 500 ± 50 nM in the absence of free ATP to 190 ± 20 nM in the presence of 0.5 mM free ATP. Thus, ATP activates the channel by sensitizing it to Ca2+. ATP therefore enhances Ca2+-induced Ca2+ release (CICR) by the InsP3R.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   [Ca2+]i dependence of the InsP3R channel Po in the presence of low (~0 mM) [ATP]i. Open triangles represent data with [ATP]i = 0 mM and [Mg2+]i = 0 mM. Open squares represent data with [ATP]i = 0 mM and [Mg2+]i = 3.0 mM. Open circles represent data with [ATP]i = 12 µM and [Mg2+]i = 2.5 mM (0.5 mM total ATP; 3 mM total Mg2+). The solid curve is the biphasic Hill equation fit using Equation 1. For comparison, Po data of the InsP3R in the presence of 0.5 mM [ATP]i (small filled circles) and the corresponding biphasic Hill equation fit (dotted curve; published in Ref. 8) are also shown.

Because InsP3 activates channel gating by modifying the [Ca2+]i inhibition phase of the channel [Ca2+]i dependence (8), we were also interested in examining the effects of ATP on this aspect of the response. However, investigations of InsP3R channel activity in the absence of free ATP at [Ca2+]i which inhibit channel gating (>20 µM; Ref. 8) were not possible because of the unavailability of a Ca2+ chelator with the appropriate Ca2+ affinity. In our previous experiments that examined the effects of high [Ca2+]i on InsP3R channel gating (8), ATP was used as the Ca2+ chelator for buffering [Ca2+]i at high [Ca2+]i. The data we were able to obtain in the absence of ATP in the present study indicated that Po began to decrease as [Ca2+]i was increased beyond 10 µM, but the inhibitory half-maximal [Ca2+]i, Kinh, or Hill coefficient, Hinh, could not be determined accurately (Fig. 2).

Effects of ATP on InsP3R Channel Kinetics-- Analysis of the mean open and closed durations of the InsP3R revealed that the mean open duration (tau o) in the absence of free ATP lay within a narrow range between 5 and 15 ms over a wide range of [Ca2+]i (1-10 µM). At both very low (<400 nM) or very high (>10 µM) [Ca2+]i, tau o was shorter (~3 ms) (Fig. 3). In contrast, the mean closed duration (tau c) in the absence of free ATP decreased about 2 orders of magnitude, from 200 to 3 ms, as [Ca2+]i was increased from 200 nM to 1 µM. tau c remained low between 1 and 10 µM [Ca2+]i (Fig. 4). These same basic kinetics were observed in all experiments conducted in the absence of cytoplasmic free ATP, regardless of the presence or absence of free Mg2+ or MgATP complex. Similar [Ca2+]i dependences of tau o and tau c (Figs. 3 and 4) were also observed in the presence of 0.5 mM free ATP (8). An examination of the differences in the [Ca2+]i dependences of tau o and tau c in either the presence and absence of cytoplasmic free ATP reveals that the mechanism whereby free ATP enhances channel activity is by stabilization of the open channel state(s) and destabilization of the closed channel state(s) in the low [Ca2+]i regime (30-500 nM). Our more limited data indicate that free ATP may also stabilize the open channel state(s) at very high [Ca2+]i (>15 µM).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   [Ca2+]i dependence of the mean open durations of the InsP3R channels in the absence of free cytoplasmic ATP (A) and in the presence of 0.5 mM free ATP (B). The symbols used are the same as those in Fig. 2.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   [Ca2+]i dependence of the mean closed durations of the InsP3R channels in the absence of free cytoplasmic ATP (A) and in the presence of 0.5 mM free ATP (B). The symbols used are the same as those in Fig. 2.

ATP Concentration Dependence of Ca2+ Activation of InsP3R Gating-- We undertook a systematic study of the activation of the InsP3R by [Ca2+]i over a wide range of free [ATP]i. In the presence of 10 µM InsP3, the activating Hill equation (Equation 2) agreed well the experimental data for [ATP]i of 4.8 and 9.5 mM, with no significant effects of [ATP]i on Hact or Pmax (Fig. 5).
P<SUB><UP>o</UP></SUB>=P<SUB><UP>max</UP></SUB>{1+(K<SUB><UP>act</UP></SUB>/[<UP>Ca<SUP>2+</SUP></UP>]<SUB>i</SUB>)<SUP>H<SUB><UP>act</UP></SUB></SUP>}<SUP><UP>−1</UP></SUP> (Eq. 2)
[ATP]i decreased Kact of the InsP3R by over an order of magnitude, from 500 ± 50 nM in 0 mM [ATP]i to 29 ± 4 nM in 9.5 mM [ATP]i. The effects of [ATP]i on Kact of the InsP3R were analyzed by fitting the data with a modified Michaelis-Menten equation (Fig. 6).
K<SUB><UP>act</UP></SUB>=K<SUB><UP>min</UP></SUB>+K<SUB><UP>r</UP></SUB>{1+([<UP>ATP</UP>]<SUB>i</SUB>/K<SUB><UP>ATP</UP></SUB>)}<SUP><UP>−1</UP></SUP> (Eq. 3)
A modification to the standard Michaelis-Menten equation was necessary because ATP alone is insufficient to activate the channel in absence of InsP3, and therefore the activating half-maximal [Ca2+]i (Kact) should not approach 0 even in presence of saturating concentrations of ATP. The results indicate that the range over which Kact of the InsP3R varies in response to [ATP]i, Kr = 480 ± 20 nM; the minimum Kact under saturating [ATP]i, Kmin = 17 ± 3 nM; and the functional dissociation coefficient for cytoplasmic free ATP activation of the InsP3R, KATP = 0.27 ± 0.04 mM. The good fit of this equation to the data suggests that ATP stimulation of channel activity is not cooperative, requiring binding of only one ATP molecule to the InsP3R tetramer to stimulate it.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of [ATP]i on activation of the InsP3R by [Ca2+]i. The different symbols plotted correspond to various [ATP]i used, as tabulated in the graph (in mM). The curves are Hill equation fits for the corresponding experimental data: for 0 mM [ATP]i, Hact = 2.4, Kact = 500 nM, and Pmax = 0.79; for 0.5 mM [ATP]i, Hact = 1.9, Kact = 190 nM, and Pmax = 0.81; for 4.8 mM [ATP]i, Hact = 2.3, Kact = 45 nM, and Pmax = 0.71; for 9.5 mM [ATP]i, Hact = 2.4, Kact = 29 nM, and Pmax = 0.82. For 0.3 mM [ATP]i, assuming that Hact = 2 and Pmax = 0.8, Hill equation fitting gives Kact = 230 nM.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of [ATP]i on the activating half-maximal [Ca2+]i (Kact) of the InsP3R. The curve is the theoretical fit based on the modified Michaelis-Menten equation (Equation 3).

Nucleotide Specificity-- To determine the nucleotide specificity of the stimulatory effects we observed for free ATP, we also investigated the effects of adenosine, AMP, ADP, GTP, and UTP. Each nucleotide was present as 0.5 mM free nucleotide in the absence of Mg2+. The [Ca2+]i was fixed at 220 ± 15 nM, because the Po is very sensitive to activation by free ATP at this [Ca2+]i (Fig. 2). Using the channel Po (0.14) in the absence of any nucleotide as the reference, the relative Po of the channel was determined in the presence of the various nucleotide species (Fig. 7). Similar to the MgATP complex, free UTP, ADP, and adenosine had no effects on the Po of the InsP3R (p > 0.05). In contrast, free ATP, AMP, and GTP each activated the InsP3R (p < 0.05). Free ATP had the greatest effect, more than tripling the Po, whereas both free AMP and GTP doubled the channel Po.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 7.   Relative open probabilities of InsP3R in the presence of 0.5 mM free cytoplasmic nucleotides. [Ca2+]i = 220 ± 15 nM. Po = 0.14 in the absence of any nucleotide. Total [Mg2+] is 3 mM for data labeled MgATP and 0 mM for the rest.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We previously described the detailed permeation and gating properties of the Xenopus type 1 InsP3R channel by patch clamp studies of isolated oocyte nuclei (8, 35, 36, 40). Under optimal conditions, gating of the channel is robust, with maximum open probability of ~80% over a wide range of [Ca2+]i (8). Importantly, the gating of the channel is regulated by both InsP3 as well as by [Ca2+]i. The regulation of the InsP3-liganded channel activity by [Ca2+]i is biphasic, with half-maximal activation at 210 nM and half-maximal inhibition at 45 µM in 10 µM InsP3. InsP3 binds noncooperatively to a high affinity site (KD ~ 50 nM) on each monomer of the channel tetramer. Binding of InsP3 to the channel has the sole effect of decreasing the Ca2+ affinity of the Ca2+ inhibition site on each monomer, in a process which has high cooperativity (Hill coefficient of 4) (8). When cytoplasmic InsP3 concentration ([InsP3]i) is low, under conditions of no or weak stimulation, the channel is inhibited by relatively low [Ca2+]i, whereas it becomes much less sensitive to Ca2+ inhibition at higher [InsP3]i, enabling it to become activated. Thus, InsP3 activates the channel by tuning the inhibition efficacy of the Ca2+ ligand. Of particular significance, [Ca2+]i activation of the channel was not modified by InsP3. However, it is unknown whether other modulators of InsP3R activity similarly impinge on the Ca2+ inhibition properties of the channel or whether the Ca2+ activation properties of the channel are exploited as an alternate method of channel regulation. The results from the present study suggest that ATP stimulates gating of the InsP3R by modulating the Ca2+ sensitivity of the Ca2+ activation sites.

Regulation of InsP3-mediated Ca2+ Release by ATP-- We performed a systematic investigation of the effects of nucleotides on gating of the Xenopus type 1 InsP3R Ca2+ release channel. Our study focused on the effects of ATP on single channel activity, and included additional examination of effects of other nucleotides for comparison. Stimulation of InsP3R by nucleotides in the presence of InsP3 has been previously reported (20-23, 42, 43). The majority of published studies measured the effects of nucleotides on InsP3-induced Ca2+ fluxes either from intracellular stores in permeabilized cells or into lipid vesicles in vitro. ATP stimulation of InsP3-induced Ca2+ fluxes was reported in all these studies, but the considerable qualitative as well as quantitative variability among them makes comparison with our results difficult. Maximum stimulation by ATP of Ca2+ release by the InsP3R has been reported to range from 1.5- to 2-fold (20-22) the activity with InsP3 alone. Considerable discrepancies exist regarding the ATP concentration required for maximal stimulation, ranging from 10 µM (20) to 1 mM (21, 22). In terms of the nucleotide specificity, ADP was reported to be as potent as ATP (21, 22) or to be only 40% as effective (20) or ineffective (24); AMP has been reported to stimulate to ~70% (21, 22) or 10% (20) of the ATP stimulation level; GTP was ineffective (21) or stimulated to 30% of the ATP stimulation level (22). Regarding the specific ATP species, MgATP complex was as effective as free ATP (20) or only 50% as effective (21).

Some reports indicate that the effects of ATP on InsP3R activity are biphasic, being stimulatory at low [ATP]i and inhibitory at high [ATP]i (20-23). The concentrations at which increased [ATP]i starts to reduce InsP3R activity have varied from 0.1 (20) to 1 mM (21, 22) in Ca2+ flux experiments. In bilayer experiments, ATP concentrations of >5 mM inhibited channel activity with a half-maximal concentration of 11 mM (23). In contrast, recent Ca2+ flux studies found no inhibitory effects of ATP at 5 (24) or 10 mM (42) on InsP3-induced Ca2+ release from the ER. The results from our nuclear patch clamp experiments are in agreement with these latter studies. We detected no inhibitory effects of cytoplasmic ATP up to 10 mM. It has been suggested that the inhibitory effects of high [ATP]i are caused by competitive inhibition of InsP3 binding to the InsP3R (23). Therefore, the different observations may be caused by different [InsP3]i used in these studies, <5 µM in studies reporting ATP inhibition (20-23) and >5 µM in studies reporting no ATP inhibition (Refs. 24 and 42 and this study).

Stimulation of Single Channel Gating of the InsP3R by ATP-- Many of the discrepancies in the results of Ca2+ flux studies may have been caused by species differences, different concentrations of InsP3, or other important parameters, including Ca2+ and other divalent cations (i.e. Mg2+) whose concentrations in the vicinity of the InsP3R might not have been adequately controlled. Furthermore, the measurements of Ca2+ fluxes involved populations of unknown numbers and multiple types of InsP3R, which may also have contributed to the discrepant results (42). Importantly, the effects of nucleotides on the activity of the InsP3R on the single molecule level can only be inferred from these studies. There has been only one previous detailed investigation of the effects of ATP on single channel activity of the InsP3R (23). In the presence of 0.2 µM [Ca2+]i and 2 µM InsP3, ATP enhanced the Po of canine cerebellum type 1 InsP3R reconstituted from microsomes into artificial planar lipid bilayers with a binding coefficient of 40 µM and Hill coefficient of 1. The MgATP complex was as effective as free ATP, whereas GTP was only 20% as effective and AMP was ineffective.

The effects of nucleotides on the Xenopus type 1 channel observed by nuclear patch clamp in the present study have some similarities but also differ in several important respects. In agreement with the results from the bilayer study, the Hill coefficient for ATP activation was also 1 in our study, although the apparent binding coefficient KATP for free ATP was ~300 µM in our study, compared with 40 µM in the bilayer study. In both studies, ATP activation of channel gating was associated with stabilization of the open state and destabilization of the closed state. Both studies concluded that ATP hydrolysis was not involved, since nonhydrolyzable analogs were as effective as ATP in the bilayer study. In contrast to the lipid bilayer results, the MgATP complex had no stimulatory effects in our study; furthermore, free GTP and AMP had potent stimulatory effects (both about 60% of the ATP stimulation level) in the present study. The difference in nucleotide specificity observed in the two studies is difficult to reconcile. It may be caused by the different sources (canine versus Xenopus), lipid environment (artificial lipid bilayers versus native ER), and/or the isolation/reconstitution protocols. Of particular interest is our finding that MgATP was without effect on the channel activity. This distinction is important; whereas the MgATP concentration in the cytoplasm is in the range of 3-8 mM (44-48), the cytoplasmic free ATP concentration is in the range of 400-600 µM. The apparent affinity of 40 µM for ATP stimulation of the InsP3R in bilayers and the apparent effectiveness of MgATP substituting for ATP in InsP3R stimulation would suggest that ATP (free or complexed with Mg2+) plays no role in channel modulation under most conditions, since the total concentration of free and magnesium-complexed ATP always far exceeds its apparent affinity for the channel. In contrast, and as discussed in more detail below, our determination that only free ATP is effective, with an apparent affinity (apparent KD ~ 270 µM) that is nearly coincident with levels in the cytoplasm, suggests that physiological modulation of ATP levels in cells will have profound effects on Ca2+ release activity of the InsP3R by modifying its CICR properties. Of note, a recent study using permeabilized lymphocytes that were engineered to express only the type 1 InsP3R found that free ATP enhanced InsP3-induced Ca2+ release with an apparent KD of 390 µM (42), in quite good agreement with our channel results.

A second important distinction between our results and those of the bilayer study concerns the mechanism by which ATP stimulates channel gating. Our results demonstrate that ATP binding to the InsP3R increases the Ca2+ sensitivity of the Ca2+ activation site of the channel. The bilayer experiments were carried out at a single [Ca2+]i (0.2 µM). The Po observed in 2 µM InsP3 increased from ~0.01 in the absence of ATP to ~0.07 in 1 mM ATP (the order of magnitude difference in absolute values of Po observed in the two studies may be due to an InsP3 insensitivity of the reconstituted channels in the bilayer study (8)). It was concluded that ATP binding to InsP3R increases the intrinsic efficacy of InsP3 to activate the InsP3R (23). However, our results demonstrate that ATP does not affect Pmax. The increased Po observed in the bilayer study can be accounted for by the increase in affinity of the Ca2+ activation site observed in the present study (Fig. 5).

Regulation of the [Ca2+]i Dependence of InsP3R Gating by ATP-- The present study represents the first systematic investigation of the effects of ATP on single channel activity of the InsP3R over a wide range of [Ca2+]i (10 nM to 20 µM). Our results reveal the major mechanism by which elevations of cytoplasmic free ATP stimulate gating of the InsP3R, by demonstrating that ATP increases the affinity of the Ca2+ activating site of the channel specifically. ATP decreased the half-maximal activating [Ca2+]i (Kact), without affecting the maximum Po. Although channel Po decreased at low [ATP]i, this could be fully reversed by increased [Ca2+]i. Therefore, ATP is not a necessary agonist for activation of the InsP3R, but rather it is an allosteric regulator, tuning the efficacy of [Ca2+]i to stimulate the activity of the InsP3-liganded InsP3R over a limited range of [Ca2+]i (10 nM to 1 µM as shown in Fig. 5). We previously showed that InsP3 activates the InsP3R solely by tuning the half-maximal inhibitory [Ca2+]i (Kinh) of the channel, whereas activation of the InsP3R by [Ca2+]i is unaffected (8). InsP3 is therefore a regulator of Ca2+-inhibition of Ca2+ release, whereas ATP is a regulator of CICR. Thus, the effect of free ATP on the activation of the InsP3R by [Ca2+]i complements the effect of InsP3. Together, [ATP]i and [InsP3]i each act as allosteric regulators to tune the activation and inhibition, respectively, of the InsP3R by [Ca2+]i.

It is not yet possible to completely describe the gating of the channel under all conditions of [Ca2+]i, [InsP3]i, and [ATP]i, because we have yet to fully characterize the effects of ATP on Ca2+ inhibition of the channel under submaximal [InsP3]. The data we obtained under saturating [InsP3] suggest the possibility that ATP also affects the Ca2+ inhibition phase of the [Ca2+]i dependence curve by making the channel less sensitive to [Ca2+]i inhibition. This mode of regulation is therefore analogous to that of InsP3. Further studies are required to define the effects of free ATP on Ca2+ inhibition of the channel and the relationship of those effects to that of InsP3. Nevertheless, it is interesting to consider the similarities involved in the regulation of channel gating by ATP and InsP3. As mentioned earlier, InsP3 is a channel activator because it decreases the affinity of the Ca2+ inhibition site of the channel. It is important to note, however, that it is not the absolute magnitude of the Ca2+ affinity of that site that is critical for InsP3R activity, but rather its relationship to that of the Ca2+ activation site. The higher Ca2+ affinity of the inhibition site keeps the channel inactive in the absence of InsP3. However, the Ca2+ affinity of the inhibition site becomes less than that of the activation site when the channel binds InsP3. It follows, therefore, that an alternate mechanism to activate the channel would be to increase the Ca2+ affinity of the activation site. Because this is a major effect of ATP, we speculate that suitable conditions could be defined in which channel gating could be activated by an increase in [ATP]i without any change in [InsP3]i. Because the relative affinities for Ca2+ of the InsP3R activation and inhibition sites is the critical factor in determining the level of channel activity, it follows that allosteric regulation of antagonistic Ca2+-binding sites by ATP and InsP3, by together tuning the Ca2+ dependence of channel gating, render the Ca2+ dependence of Ca2+ release by the InsP3R a dynamic property, dependent upon stimulus intensity and cell metabolic state.

Physiological Implications-- The results of our study suggest that complex features of InsP3-induced [Ca2+]i signals will be dependent upon an elaborate regulation of Ca2+ release through the InsP3R by [Ca2+]i, [InsP3]i, and [ATP]i. Importantly, modulation of channel activity by both ATP and InsP3 is achieved by regulating the [Ca2+]i dependence of channel gating. The interplay between [ATP]i and [Ca2+]i in the control of InsP3R channel activities observed in the present study probably has important physiological significance, particularly if the InsP3R actually experiences various [ATP]i. Our results indicate that the apparent affinity of the ATP-binding site on the InsP3R is physiologically relevant, since it approximates the free ATP concentration in the cytoplasm. Estimates of total Mg2+ (44, 45) and total ATP (46-48) concentrations in cells are each in the range of 5-10 mM. Assuming equal concentrations of each, the free ATP concentration is calculated to vary roughly from 420 µM (5 mM total Mg2+) to 540 µM (8 mM total Mg2+). For comparison, the apparent affinity of the ATP-binding site on the InsP3R was determined in the present study to be 270 µM. Interestingly, not only is the apparent affinity of the ATP-binding site on the InsP3R coincident with the normal cytoplasmic free ATP concentration, but changes in free ATP concentration are very sensitive to changes in total ATP concentration in the cytoplasm. For example, at 5 mM total Mg2+, an increase of total ATP concentration from 5 to 5.5 mM (10% change) will result in a 1.5-fold increase in the concentration of free ATP (from ~420 µM to ~600 µM). Thus, relatively small changes in total cytoplasmic ATP can have pronounced effects on free ATP concentration and, therefore, on the CICR properties of the InsP3R. Thus, our results suggest that the channel is poised in vivo to respond to changes in the free ATP concentration, for example those that may occur during ischemia. Therefore, the nucleotide sensitivity may enable Ca2+ release properties of the InsP3R to be tuned to the metabolic state of the cell.

It has become evident from several recent studies that mitochondria and the ER form a tightly coupled, complex signaling unit. Imaging studies have revealed that mitochondria are in close physical proximity to the ER (25), especially to sites of Ca2+ release (26). In cerebellar Purkinje cells, ER cisternae containing high densities of InsP3R-1 are often wrapped around or closely apposed to mitochondria (49, 50). A physiological implication of this structural arrangement is that it enables the rise in [Ca2+]i caused by agonist-stimulated InsP3R activity to be effectively transmitted as a transient increase in mitochondrial matrix [Ca2+] that closely parallels the [Ca2+]i rise, due to the locally high [Ca2+]i in the microdomain of the release channels and rapid uptake of released Ca2+ by the mitochondria (28-30, 33, 51). The resulting changes in mitochondrial matrix [Ca2+] affect the mitochondrial membrane potential (32) and the activities of the mitochondrial dehydrogenases that are crucial in ATP synthesis and intracellular ATP levels (27, 31, 33, 34, 52). The cytosolic ATP concentration in turn affects processes that contribute to [Ca2+]i regulation, including InsP3-induced Ca2+ release (Refs. 20-24 and 43 and this study), passive leak from Ca2+ stores (53), plasma membrane store-operated Ca2+ entry (24, 54, 55), and Ca2+ extrusion and uptake into the ER by Ca2+-ATPases (24, 56, 57). Thus, in addition to buffering [Ca2+]i directly by active Ca2+ sequestration and export (58-62), mitochondria indirectly participate in intracellular Ca2+ signaling, using cytosolic ATP as a global cytoplasmic messenger. We speculate that the close physical proximity of mitochondria and ER may enable local changes in ATP concentration, due to release from mitochondria into the microdomains of close ER-mitochondria apposition, to rapidly effect local InsP3R-mediated Ca2+ release. Of significance, the ATP released by mitochondria is free ATP, the InsP3R ligand, not MgATP (63). Thus, communication between these two organelles may be two-way, with local Ca2+ release as the currency of communication from ER to mitochondria and local ATP release providing the cross-talk from mitochondria to ER.

The phosphoinositide signaling system is highly expressed throughout the brain (64, 65). Recent observations suggest that Ca2+ release from type 1 InsP3 receptors is involved in nerve growth (66) and synaptic plasticity, including long term potentiation (67-69) and depression (LTD) (67, 67, 70-72). Disruption of the mouse InsP3R-1 gene eliminates LTD in the cerebellum (70), and the competitive InsP3R inhibitor heparin blocks LTD in the neocortex (73). Metabotropic glutamate receptors (mGluR), which couple to the InsP3 signaling pathway, have been implicated in synaptic plasticity (65, 69, 73), and mice with targeted disruption of mGluR1 show impaired LTD (74, 75). InsP3-mediated LTD in Purkinje cell dendrites was recently shown to be spatially restricted to sites where both mGluR and InsP3R are located (71). Ca2+ influx through N-methyl-D-aspartate receptors and voltage-gated channels is considered to be of major importance in synaptic plasticity (65). Synaptic plasticity in several different brain regions requires both Ca2+ entry and mGluR/InsP3R (72, 76, 77), and it been suggested that Ca2+ influx might serve to trigger Ca2+ release by CICR (65, 69, 78), with InsP3Rs therefore playing a critical role in amplifying the Ca2+ influx signal (65). Importantly, [Ca2+]i signaling in nonexcitable cells is also associated with both Ca2+ release from stores and Ca2+ influx, and Ca2+ influx has been demonstrated to play a similar role in amplifying and modifying InsP3-mediated [Ca2+]i signals (79). By demonstrating that the Ca2+ sensitivity of CICR by the InsP3R-1 can be regulated, our data raise the possibility that synaptic plasticity and other cellular processes involving InsP3Rs may be modulated by physiological stimuli that impinge on the Ca2+ sensitivity of the release channel. The results of the present study suggest that cytoplasmic ATP, and therefore the metabolic status of the cell, may be relevant in this respect. Of note, phospholipase C activity in brain tissue is enhanced in response to ischemia (80), and exposure of hippocampal slices to anoxia (81) or 2-deoxyglucose (13), manipulations expected to alter cytoplasmic ATP concentrations, induce long term potentiation. Directed studies of the role of cell metabolic state and cytoplasmic ATP concentrations in controlling InsP3-mediated Ca2+ release will be required to determine the relevance of ATP regulation of InsP3R gating for synaptic plasticity as well as other cellular processes.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence and reprint requests should be addressed: Dept. of Physiology, University of Pennsylvania, B39 ANAT-CHEM, Philadelphia, PA 19104-6085. Tel.: 215-898-1354; Fax: 215-573-6808; E-mail: foskett@mail.med.upenn.edu.

    ABBREVIATIONS

The abbreviations used are: InsP3, inositol 1,4,5-trisphosphate; InsP3R, InsP3 receptor; ER, endoplasmic reticulum; BAPTA, 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; LTD, long term depression; mGluR, metabotropic glutamate receptor(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Taylor, C. W., and Richardson, A. (1991) Pharmacol. Ther. 51, 97-137[CrossRef][Medline] [Order article via Infotrieve]
2. Berridge, M. J. (1993) Nature 361, 315-325[CrossRef][Medline] [Order article via Infotrieve]
3. Putney, J. W., Jr., St, J., and Bird, G. (1993) Endocr. Rev. 14, 610-631[Abstract/Free Full Text]
4. Carter, T. D., and Ogden, D. (1997) J. Physiol. (Lond.) 504, 17-33[Abstract/Free Full Text]
5. Meyer, T., Holowka, D., and Stryer, L. (1988) Science 240, 653-655[Abstract/Free Full Text]
6. Finch, E. A., Turner, T. J., and Goldin, S. M. (1991) Science 252, 443-446[Abstract/Free Full Text]
7. Dufour, J.-F., Arias, I. M., and Turner, T. J. (1997) J. Biol. Chem. 272, 2675-2681[Abstract/Free Full Text]
8. Mak, D.-O. D., McBride, S., and Foskett, J. K. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 15821-15825[Abstract/Free Full Text]
9. Iino, M. (1990) J. Gen. Physiol. 95, 1103-1122[Abstract/Free Full Text]
10. Marshall, I. C. B., and Taylor, C. W. (1993) J. Biol. Chem. 268, 13214-13220[Abstract/Free Full Text]
11. Bezprozvanny, I., Watras, J., and Ehrlich, B. E. (1991) Nature 351, 751-754[CrossRef][Medline] [Order article via Infotrieve]
12. Meyer, T., and Stryer, L. (1991) Annu. Rev. Biophys. Biophys. Chem. 20, 153-174[CrossRef][Medline] [Order article via Infotrieve]
13. Tekkok, S., and Krnjevic, K. (1996) J. Neurophysiol. 76, 2343-2352[Abstract/Free Full Text]
14. Toescu, E. C. (1995) Am. J. Physiol. 269, G173-G185[Abstract/Free Full Text]
15. Bootman, M. D. (1994) Mol. Cell. Endocrinol. 98, 157-166[CrossRef][Medline] [Order article via Infotrieve]
16. Mignery, G. A., Sudhof, T. C., Takei, K., and De Camilli, P. (1989) Nature 342, 192-195[CrossRef][Medline] [Order article via Infotrieve]
17. Mikoshiba, K. (1993) Trends Pharmacol. Sci. 14, 86-89[CrossRef][Medline] [Order article via Infotrieve]
18. Taylor, C. W., and Traynor, D. (1995) J. Membr. Biol. 145, 109-118[Medline] [Order article via Infotrieve]
19. Maeda, N., Kawasaki, T., Nakade, S., Yokota, N., Taguchi, T., Kasai, M., and Mikoshiba, K. (1991) J. Biol. Chem. 266, 1109-1116[Abstract/Free Full Text]
20. Ferris, C. D., Huganir, R. L., and Snyder, S. H. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2147-2151[Abstract/Free Full Text]
21. Iino, M. (1991) J. Gen. Physiol. 98, 681-698[Abstract/Free Full Text]
22. Missiaen, L., Parys, J. B., De Smedt, H., Sienaert, I., Sipma, H., Vanlingen, S., Maes, K., and Casteels, R. (1997) Biochem. J. 325, 661-666
23. Bezprozvanny, I., and Ehrlich, B. E. (1993) Neuron 10, 1175-1184[CrossRef][Medline] [Order article via Infotrieve]
24. Landolfi, B., Curci, S., Debellis, L., Pozzan, T., and Hofer, A. M. (1998) J. Cell Biol. 142, 1235-1243[Abstract/Free Full Text]
25. Rizzuto, R., Pinton, P., Carrington, W., Fay, F. S., Fogarty, K. E., Lifshitz, L. M., Tuft, R. A., and Pozzan, T. (1998) Science 280, 1763-1766[Abstract/Free Full Text]
26. Simpson, P. B., Mehotra, S., Lange, G. D., and Russell, J. T. (1997) J. Biol. Chem. 272, 22654-22661[Abstract/Free Full Text]
27. Robb-Gaspers, L. D., Rutter, G. A., Burnett, P., Hajnóczky, G., Denton, R. M., and Thomas, A. P. (1998) Biochim. Biophys. Acta 1366, 17-32[Medline] [Order article via Infotrieve]
28. Rizzuto, R., Brini, M., Murgia, M., and Pozzan, T. (1993) Science 262, 744-747[Abstract/Free Full Text]
29. Rizzuto, R., Bastianutto, C., Brini, M., Murgia, M., and Pozzan, T. (1994) J. Cell Biol. 126, 1183-1194[Abstract/Free Full Text]
30. Csordás, G., Thomas, A. P., and Hajnóczky, G. (1999) EMBO J. 18, 96-108[CrossRef][Medline] [Order article via Infotrieve]
31. McCormack, J. G., and Denton, R. M. (1993) Dev. Neurosci. 15, 165-173[Medline] [Order article via Infotrieve]
32. Loew, L. M., Carrington, W., Tuft, R. A., and Fay, F. S. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12579-12583[Abstract/Free Full Text]
33. Rutter, G. A., Burnett, P., Rizzuto, R., Brini, M., Murgia, M., Pozzan, T., Tavaré, J. M., and Denton, R. M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5489-5494[Abstract/Free Full Text]
34. Robb-Gaspers, L. D., Burnett, P., Rutter, G. A., Denton, R. M., Rizzuto, R., and Thomas, A. P. (1998) EMBO J. 17, 4987-5000[CrossRef][Medline] [Order article via Infotrieve]
35. Mak, D.-O. D., and Foskett, J. K. (1994) J. Biol. Chem. 269, 29375-29378[Abstract/Free Full Text]
36. Mak, D.-O. D., and Foskett, J. K. (1997) J. Gen. Physiol. 109, 571-587[Abstract/Free Full Text]
37. Stehno-Bittel, L., Lückhoff, A., and Clapham, D. E. (1995) Neuron 14, 163-167[CrossRef][Medline] [Order article via Infotrieve]
38. Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N., and Mikoshiba, K. (1989) Nature 342, 32-38[CrossRef][Medline] [Order article via Infotrieve]
39. Mignery, G. A., Newton, C. L., Archer, B. T., III, and Sudhof, T. C. (1990) J. Biol. Chem. 265, 12679-12685[Abstract/Free Full Text]
40. Mak, D.-O. D, and Foskett, J. K. (1998) Am. J. Physiol. 275, C179-C188
41. Kume, S., Muto, A., Aruga, J., Nakagawa, T., Michikawa, T., Furuichi, T., Nakade, S., Okano, H., and Mikoshiba, K. (1993) Cell 73, 555-570[CrossRef][Medline] [Order article via Infotrieve]
42. Miyakawa, T., Maeda, A., Yamazawa, T., Hirose, K., Kurosake, T., and Iino, M. (1999) EMBO J. 18, 1303-1308[CrossRef][Medline] [Order article via Infotrieve]
43. Missiaen, L., Parys, J. B., Sienaert, I., Maes, K., Kunzelmann, K., Takahashi, M., Tanzawa, K., and De Smedt, H. (1998) J. Biol. Chem. 273, 8983-8986[Abstract/Free Full Text]
44. Corkey, B. E., Duszynski, J., Rich, T. L., Matschinsky, B., and Williamson, J. R. (1986) J. Biol. Chem. 261, 2567-2574[Abstract/Free Full Text]
45. Flatman, P. W. (1991) Annu. Rev. Physiol. 53, 259-271[CrossRef][Medline] [Order article via Infotrieve]
46. Dunne, M. J., West-Jordan, J. A., Abraham, R. J., Edwards, R. T. H., and Petersen, O. H. (1988) J. Membr. Biol. 104, 165-172[CrossRef][Medline] [Order article via Infotrieve]
47. Kargacin, M. E., and Kargacin, G. J. (1997) Am. J. Physiol. 273, C1416-C1426
48. Maechler, P., Wang, H. Y., and Wollheim, C. B. (1998) FEBS Lett. 422, 328-332[CrossRef][Medline] [Order article via Infotrieve]
49. Otsu, H., Yamamoto, A., Maeda, N., Mikoshiba, K., and Tashiro, Y. (1990) Cell Struct. Funct. 15, 163-173[Medline] [Order article via Infotrieve]
50. Satoh, T., Ross, C. A., Villa, A., Supattapone, S., Pozzan, T., Snyder, S. H., and Meldolesi, J. (1990) J. Cell Biol. 111, 615-624[Abstract/Free Full Text]
51. Babcock, D. F., and Hille, B. (1998) Curr. Opin. Neurobiol. 8, 398-404[CrossRef][Medline] [Order article via Infotrieve]
52. Hajnóczky, G., Robb-Gaspers, L. D., Seitz, M. B., and Thomas, A. P. (1995) Cell 82, 415-424[CrossRef][Medline] [Order article via Infotrieve]
53. Hofer, A. M., Curci, S., Machen, T. E., and Schulz, I. (1996) FASEB J. 10, 302-308[Abstract]
54. Gamberucci, A., Innocenti, B., Fulceri, R., Bànhegyi, G., Giunti, R., Pozzan, T., and Benedetti, A. (1994) J. Biol. Chem. 269, 23597-23602[Abstract/Free Full Text]
55. Marriott, I., and Mason, M. J. (1995) Am. J. Physiol. Cell Physiol. 269, C766-C774[Abstract/Free Full Text]
56. Fasolato, C., Zottini, M., Clementi, E., Zacchetti, D., Meldolesi, J., and Pozzan, T. (1991) J. Biol. Chem. 266, 20159-20167[Abstract/Free Full Text]
57. Al-Baldawi, N. F., Moore, J. E., and Abercrombie, R. F. (1993) J. Physiol. (Lond.) 461, 633-646[Abstract/Free Full Text]
58. Martínez-Serrano, A., and Satrústegui, J. (1992) Mol. Biol. Cell 3, 235-248[Abstract]
59. Jouaville, L. S., Ichas, F., Holmuhamedov, E. L., Camacho, P., and Lechleiter, J. D. (1995) Nature 377, 438-441[CrossRef][Medline] [Order article via Infotrieve]
60. Simpson, P. B., and Russell, J. T. (1996) J. Biol. Chem. 271, 33493-33501[Abstract/Free Full Text]
61. Babcock, D. F., Herrington, J., Goodwin, P. C., Park, Y. B., and Hille, B. (1997) J. Cell Biol. 136, 833-844[Abstract/Free Full Text]
62. Ichas, F., Jouaville, L. S., and Mazat, J. P. (1997) Cell 89, 1145-1153[CrossRef][Medline] [Order article via Infotrieve]
63. Klingenberg, M. (1980) J. Membr. Biol. 56, 97-105[CrossRef][Medline] [Order article via Infotrieve]
64. Furuichi, T., and Mikoshiba, K. (1995) J. Neurochem. 64, 953-960[Medline] [Order article via Infotrieve]
65. Berridge, M. J. (1998) Neuron 21, 13-26[CrossRef][Medline] [Order article via Infotrieve]
66. Takei, K., Shin, R.-M., Inoue, T., Kato, K., and Mikoshiba, K. (1998) Science 282, 1705-1708[Abstract/Free Full Text]
67. Khodakhah, K., and Armstrong, C. M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14009-14014[Abstract/Free Full Text]
68. Komatsu, Y. (1996) J. Neurosci. 16, 6342-6352[Abstract/Free Full Text]
69. Kasai, H., and Petersen, O. H. (1994) Trends Neurosci. 17, 95-101[CrossRef][Medline] [Order article via Infotrieve]
70. Inoue, T., Kato, K., Kohda, K., and Mikoshiba, K. (1998) J. Neurosci. 18, 5366-5373[Abstract/Free Full Text]
71. Finch, E. A., and Augustine, G. J. (1998) Nature 396, 753-756[CrossRef][Medline] [Order article via Infotrieve]
72. Linden, D. J., and Connor, J. A. (1995) Annu. Rev. Neurosci. 18, 319-357[CrossRef][Medline] [Order article via Infotrieve]
73. Kato, N. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3650-3654[Abstract/Free Full Text]
74. Conquet, F., Bashir, Z. I., Davies, C. H., Daniel, H., Ferraguti, F., Bordi, F., Franz-Bacon, K., Reggiani, A., Matarese, V., Conde, F., Collingridge, G. L., and Crepel, F. (1994) Nature 372, 237-243[CrossRef][Medline] [Order article via Infotrieve]
75. Aiba, A., Kano, M., Chen, M. C., Stanton, M. E., Fox, G. D., Herrup, K., Zwingman, T. A., and Tonegawa, S. (1994) Cell 79, 377-388[CrossRef][Medline] [Order article via Infotrieve]
76. Ito, M. (1989) Annu. Rev. Neurosci. 12, 85-102[CrossRef][Medline] [Order article via Infotrieve]
77. Otani, S., and Connor, J. A. (1998) J. Physiol. 511, 761-770[Abstract/Free Full Text]
78. Llano, I., DiPolo, R., and Marty, A. (1994) Neuron 12, 663-673[CrossRef][Medline] [Order article via Infotrieve]
79. Girard, S. E., and Clapham, D. E. (1993) Science 260, 229-232[Abstract/Free Full Text]
80. Nagata, E., Tanaka, K., Gomi, S., Mihara, B., Shirai, T., Nogawa, S., Nozaki, H., Mikoshiba, K., and Fukuuchi, Y. (1994) Neuroscience 61, 983-990[CrossRef][Medline] [Order article via Infotrieve]
81. Hsu, K. S., and Huang, C. C. (1997) Br. J. Pharmacol. 122, 671-681[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. J. Betzenhauser, L. E. Wagner II, H. S. Park, and D. I. Yule
ATP Regulation of Type-1 Inositol 1,4,5-Trisphosphate Receptor Activity Does Not Require Walker A-type ATP-binding Motifs
J. Biol. Chem., June 12, 2009; 284(24): 16156 - 16163.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. K. Nagaleekar, S. A. Diehl, I. Juncadella, C. Charland, N. Muthusamy, S. Eaton, L. Haynes, L. A. Garrett-Sinha, J. Anguita, and M. Rincon
IP3 Receptor-Mediated Ca2+ Release in Naive CD4 T Cells Dictates Their Cytokine Program
J. Immunol., December 15, 2008; 181(12): 8315 - 8322.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. S. Park, M. J. Betzenhauser, J. H. Won, J. Chen, and D. I. Yule
The Type 2 Inositol (1,4,5)-Trisphosphate (InsP3) Receptor Determines the Sensitivity of InsP3-induced Ca2+ Release to ATP in Pancreatic Acinar Cells
J. Biol. Chem., September 19, 2008; 283(38): 26081 - 26088.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Betzenhauser, L. E. Wagner II, M. Iwai, T. Michikawa, K. Mikoshiba, and D. I. Yule
ATP Modulation of Ca2+ Release by Type-2 and Type-3 Inositol (1, 4, 5)-Triphosphate Receptors: DIFFERING ATP SENSITIVITIES AND MOLECULAR DETERMINANTS OF ACTION
J. Biol. Chem., August 1, 2008; 283(31): 21579 - 21587.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. E. Wagner II, S. K. Joseph, and D. I. Yule
Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation
J. Physiol., August 1, 2008; 586(15): 3577 - 3596.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. M. Power and P. Sah
Competition between Calcium-Activated K+ Channels Determines Cholinergic Action on Firing Properties of Basolateral Amygdala Projection Neurons
J. Neurosci., March 19, 2008; 28(12): 3209 - 3220.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak
Inositol Trisphosphate Receptor Ca2+ Release Channels
Physiol Rev, April 1, 2007; 87(2): 593 - 658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. White, J. Yang, M. J. Monteiro, and J. K. Foskett
CIB1, a Ubiquitously Expressed Ca2+-binding Protein Ligand of the InsP3 Receptor Ca2+ Release Channel
J. Biol. Chem., July 28, 2006; 281(30): 20825 - 20833.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. E. Wagner II, M. J. Betzenhauser, and D. I. Yule
ATP Binding to a Unique Site in the Type-1 S2- Inositol 1,4,5-Trisphosphate Receptor Defines Susceptibility to Phosphorylation by Protein Kinase A
J. Biol. Chem., June 23, 2006; 281(25): 17410 - 17419.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F.-X. Yi and I. M. Bird
Pregnancy-Specific Modulatory Role of Mitochondria on Adenosine 5'-Triphosphate-Induced Cytosolic [Ca2+] Signaling in Uterine Artery Endothelial Cells
Endocrinology, November 1, 2005; 146(11): 4844 - 4850.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. Dumollard, P. Marangos, G. Fitzharris, K. Swann, M. Duchen, and J. Carroll
Sperm-triggered [Ca2+] oscillations and Ca2+ homeostasis in the mouse egg have an absolute requirement for mitochondrial ATP production
Development, July 1, 2004; 131(13): 3057 - 3067.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
D.-O. D. Mak, S. M.J. McBride, and J. K. Foskett
Spontaneous Channel Activity of the Inositol 1,4,5-Trisphosphate (InsP3) Receptor (InsP3R). Application of Allosteric Modeling to Calcium and InsP3 Regulation of InsP3R Single-channel Gating
J. Gen. Physiol., October 27, 2003; 122(5): 583 - 603.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. Dumollard, K. Hammar, M. Porterfield, P. J. Smith, C. Cibert, C. Rouviere, and C. Sardet
Mitochondrial respiration and Ca2+ waves are linked during fertilization and meiosis completion
Development, February 15, 2003; 130(4): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. C. Lenz, H. P. Reusch, N. Albrecht, G. Schultz, and M. Schaefer
Ca2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells
J. Cell Biol., October 28, 2002; 159(2): 291 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Dumollard, J. Carroll, G. Dupont, and C. Sardet
Calcium wave pacemakers in eggs
J. Cell Sci., September 15, 2002; 115(18): 3557 - 3564.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. H. Yoo, Y. S. Oh, M. K. Kang, Y. H. Huh, S. H. So, H. S. Park, and H. Y. Park
Localization of Three Types of the Inositol 1,4,5-Trisphosphate Receptor/Ca2+ Channel in the Secretory Granules and Coupling with the Ca2+ Storage Proteins Chromogranins A and B
J. Biol. Chem., November 30, 2001; 276(49): 45806 - 45812.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Missiaen, H. DeSmedt, G. Bultynck, S. Vanlingen, P. Desmet, G. Callewaert, and J. B. Parys
Calmodulin Increases the Sensitivity of Type 3 Inositol-1,4,5-trisphosphate Receptors to Ca2+ Inhibition in Human Bronchial Mucosal Cells
Mol. Pharmacol., March 1, 2000; 57(3): 564 - 567.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Boehning and S. K. Joseph
Functional Properties of Recombinant Type I and Type III Inositol 1,4,5-Trisphosphate Receptor Isoforms Expressed in COS-7 Cells
J. Biol. Chem., July 7, 2000; 275(28): 21492 - 21499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. S. Marchant, V. Ramos, and I. Parker
Structural and functional relationships between Ca2+ puffs and mitochondria in Xenopus oocytes
Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1374 - C1386.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mak, D.-O. D.
Right arrow Articles by Foskett, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mak, D.-O. D.
Right arrow Articles by Foskett, J. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement